Deval Jerome, Jin Zhinan, Chuang Ying-Chih, Kao C Cheng
Alios BioPharma, Inc., Part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA.
Alios BioPharma, Inc., Part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA.
Virus Res. 2017 Apr 15;234:21-33. doi: 10.1016/j.virusres.2016.12.018. Epub 2016 Dec 29.
Noroviruses belong to the Caliciviridae family of single-stranded positive-sense RNA viruses. The genus Norovirus includes seven genogroups (designated GI-GVII), of which GI, GII and GIV infect humans. Human noroviruses are responsible for widespread outbreaks of acute gastroenteritis and represent one of the most common causes of foodborne illness. No vaccine or antiviral treatment options are available for norovirus infection. The RNA-dependent RNA polymerase (RdRp) of noroviruses is a key enzyme responsible for transcription and replication of the viral genome. Here, we review the progress made in understanding the structures and functions of norovirus RdRp and its use as a target for small molecule inhibitors. Crystal structures of the RdRp at different stages of substrate interaction have been determined, which shed light on its multi-step catalytic cycle. The in vitro assays and in vivo animal models that have been developed to identify and characterize inhibitors of norovirus RdRp are also summarized, followed by an update on the current antiviral research targeting different regions of norovirus RdRp. In the future, structure-based drug design and rational optimization of known nucleoside and non-nucleoside inhibitors of norovirus RdRp may pave the way towards the next generation of direct-acting antivirals.
诺如病毒属于单链正义RNA病毒的杯状病毒科。诺如病毒属包括七个基因组(命名为GI - GVII),其中GI、GII和GIV感染人类。人类诺如病毒是急性胃肠炎广泛爆发的原因,也是食源性疾病最常见的病因之一。目前尚无针对诺如病毒感染的疫苗或抗病毒治疗方法。诺如病毒的RNA依赖性RNA聚合酶(RdRp)是负责病毒基因组转录和复制的关键酶。在此,我们综述了在理解诺如病毒RdRp的结构和功能及其作为小分子抑制剂靶点方面所取得的进展。已确定了RdRp在底物相互作用不同阶段的晶体结构,这为其多步催化循环提供了线索。还总结了为鉴定和表征诺如病毒RdRp抑制剂而开发的体外试验和体内动物模型,随后介绍了针对诺如病毒RdRp不同区域的当前抗病毒研究进展。未来,基于结构的药物设计以及对诺如病毒RdRp已知核苷和非核苷抑制剂的合理优化,可能为下一代直接作用抗病毒药物铺平道路。